Frequently Asked Questions about Equillium, Inc. (EQ)

Name: Equillium, Inc. (EQ) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Equillium, Inc. (EQ) do?

Accepted Answer

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets th...

Question 2

Is Equillium, Inc. (EQ) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of EQ reveals an Altman Z-Score of 0.79 and a Piotroski F-Score of 1/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if EQ fits their risk profile.

Question 3

What is the current P/E ratio for EQ?

Accepted Answer

As of the latest trading session, Equillium, Inc. (EQ) has a trailing P/E ratio of -7.84.

Question 4

Who is the CEO of Equillium, Inc.?

Accepted Answer

The current Chief Executive Officer of Equillium, Inc. is Bruce D. Steel.

Question 5

What was EQ's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Equillium, Inc. reported annual revenues of $0.00B (2025), $0.04B (2024), $0.04B (2023), $0.02B (2022), $0.00B (2021) respectively.

Question 6

Does EQ pay a dividend?

Accepted Answer

Equillium, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does EQ have?

Accepted Answer

In its latest reporting period, Equillium, Inc. generated $-0.02B in Free Cash Flow against a total debt load of $0.00B.

Question 8

What is the Price-to-Book (P/B) ratio of Equillium, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Equillium, Inc. (EQ) is currently 6.14.

Question 9

What is the Price-to-Sales (P/S) ratio of EQ?

Accepted Answer

Based on trailing twelve-month data, Equillium, Inc. (EQ) trades at a Price-to-Sales (P/S) ratio of 0.00.

Question 10

What is Equillium, Inc.'s Return on Equity (ROE)?

Accepted Answer

Equillium, Inc. (EQ) has a Return on Equity (ROE) of -119.19%, representing its profitability relative to shareholder equity.

Period	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt
2025-12	31.9M	3.3M	28.6M	719K	-29.6M
2024-12	25.6M	6.5M	19.1M	384K	-17.7M
2023-12	50.5M	28M	22.6M	824K	-22.4M
2022-12	78.4M	46.5M	31.9M	10.2M	-48.9M
2021-12	85.4M	18.9M	66.5M	11.8M	-38.6M

Period	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt
2025-12	31.9M	3.3M	28.6M	719K	-29.6M
2024-12	25.6M	6.5M	19.1M	384K	-17.7M
2023-12	50.5M	28M	22.6M	824K	-22.4M
2022-12	78.4M	46.5M	31.9M	10.2M	-48.9M
2021-12	85.4M	18.9M	66.5M	11.8M	-38.6M